News & Research

PSMA PET-CT Superior for Staging High-Risk Prostate Cancer

Posted on by Info
  PSMA positron emission tomography-computed tomography (PSMA PET-CT) offers a more accurate way to stage men with high-risk localized prostate cancer than conventional imaging, according to investigators. “PSMA PET-CT is a suitable replacement for conventional imaging, providing superior accuracy, to the combined findings of CT and bone scanning,” Michael S. Hofman, MBBS, of the Peter MacCallum Cancer Centre in Victoria,...Read More

Prostate Cancer Treatment Side Effects Worse With Prostatectomy

Posted on by Info
  Men with localized prostate cancer (PCa) who undergo prostatectomy report worse urinary incontinence through 5 years compared with other management options, according to new study findings published in JAMA. Patients with unfavorable-risk disease also report worse sexual function at 5 years after surgery compared with external beam radiation therapy (EBRT) with androgen deprivation therapy (ADT). Karen E. Hoffman, MD, MHSc,...Read More

Do Biopsies Spread Cancer?

Posted on by Info
  Cancer is almost always diagnosed by biopsy, a surgical procedure that removes tissue samples from tumors.  The samples are viewed under a microscope by a pathologist to determine the presence and type of cancer.  According to TMD Limited, a medical tourism company, it is the fear of biopsies spreading cancer that drives over half a million US citizens out...Read More

Can a man develop erectile dysfunction (ED) after a prostate biopsy?

Posted on by Info
  Erectile dysfunction (ED) can occur after prostate biopsy, but the reasons for this are unclear. Some men do recover their function in a few months, however. When a man has a prostate biopsy, small samples (cores) of prostate tissue are removed and checked for cancer cells. To collect the samples, a urologist uses a small needle. Generally, there are...Read More

Prebiopsy MRI can ‘transform’ prostate cancer care, study finds

Posted on by Info
  Prebiopsy multiparametric MRI (mpMRI) paired with targeted biopsy can improve the detection of clinically significant prostate cancer, according to a study published in JAMA Network Open. Identifying high-risk from low-risk prostate cancers can spare men from unnecessary invasive treatments and treatment-associated morbidity, wrote first author Martha M. C. Elwenspoek, PhD, but doing so remains difficult. “There is, therefore, an...Read More